News
Race for approval: biotechs accelerate bipolar disorder therapies
9+ hour, 25+ min ago (586+ words) Bipolar disorder affects more than 40 million people in the world, and the depressive phase is the predominant and most disabling state for the majority of patients. It causes physical changes in the brain’s emotion control centers and the chemical messengers,…...
Six psychedelic drug companies aiming to revolutionize mental health treatment
11+ mon, 3+ day ago (706+ words) Psychedelic drugs have the potential to become an effective treatment for crippling mental health conditions such as depression. In this article, we take a look at six of the top psychedelic companies leading their particular niches in the field of…...